Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: An overview

Molecular and Cellular Endocrinology

Volumn 350, Issue 2, 2012, Pages 168-186

  Odermatt, Alex ^a   Kratschmar, Denise V ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

11 Hydroxysteroid dehydrogenase; Aldosterone; Cortisol; Glucocorticoid receptor; Mineralocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTICOSTERONE; CORTISONE; DEXAMETHASONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DROSPIRENONE; EPLERENONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; LOOP DIURETIC AGENT; METHYLPREDNISOLONE; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; PREDNISOLONE; PREDNISONE; SPIRONOLACTONE; TRIAMCINOLONE; UNINDEXED DRUG;

ADIPOSE TISSUE; ADRENAL GLAND; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNE DISEASE; BONE; BRAIN; CELL SPECIFICITY; CONCENTRATION RESPONSE; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG POTENTIATION; FRACTURE; GASTROINTESTINAL TRACT; HEART; HEART FAILURE; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY; MEMORY DISORDER; NONHUMAN; OBESITY; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SKELETAL MUSCLE; SKIN; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; BRAIN; ENDOCRINE GLANDS; HUMANS; IMMUNE SYSTEM; KIDNEY; MODELS, BIOLOGICAL; MUSCLES; ORGAN SPECIFICITY; RECEPTORS, MINERALOCORTICOID;

EID: 84856335862     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.020     Document Type: Review

References (224)

1. Abu E.O., Horner A., Kusec V., Triffitt J.T., Compston J.E. The localization of the functional glucocorticoid receptor alpha in human bone. J. Clin. Endocrinol. Metab. 2000, 85:883-889.
2. Ackermann D., Gresko N., Carrel M., Loffing-Cueni D., Habermehl D., Gomez-Sanchez C., Rossier B.C., Loffing J. In vivo nuclear translocation of mineralocorticoid and glucocorticoid receptors in rat kidney: differential effect of corticosteroids along the distal tubule. Am. J. Physiol. 2010, 299:F1473-F1485.
3. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J. Biol. Chem. 1989, 264:18939-18943.
4. Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 1994, 269:25959-25962.
5. Agarwal M.K., Mirshahi F., Mirshahi M., Bracq S., Chentoufi J., Hott M., Jullienne A., Marie P.J. Evidence for receptor-mediated mineralocorticoid action in rat osteoblastic cells. Am. J. Physiol. 1996, 270:C1088-C1095.
6. Ahima R.S., Harlan R.E. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 1990, 39:579-604.
7. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 1994, 105:R11-R17.
8. Albiston A.L., Smith R.E., Krozowski Z.S. Sex- and tissue-specific regulation of 11 beta-hydroxysteroid dehydrogenase mRNA. Mol. Cell. Endocrinol. 1995, 109:183-188.
9. Alzamora R., Michea L., Marusic E.T. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 2000, 35:1099-1104.
10. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987, 237:268-275.
11. Arriza J.L., Simerly R.B., Swanson L.W., Evans R.M. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988, 1:887-900.
12. Atanasov A.G., Nashev L.G., Schweizer R.A., Frick C., Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett. 2004, 571:129-133.
13. Barnes P.J. Mechanisms and resistance in glucocorticoid control of inflammation. J. Steroid Biochem. Mol. Biol. 2010, 120:76-85.
14. Baschant U., Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 2010, 120:69-75.
15. Batista M.C., Mendonca B.B., Kater C.E., Arnhold I.J., Rocha A., Nicolau W., Bloise W. Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. J. Pediatr. 1986, 109:989-993.
16. Beavan S., Horner A., Bord S., Ireland D., Compston J. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J. Bone Miner. Res. 2001, 16:1496-1504.
17. Bendtzen K., Hansen P.R., Rieneck K. Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin. Exp. Immunol. 2003, 134:151-158.
18. Berger S., Cole T.J., Schmid W., Schutz G. Analysis of glucocorticoid and mineralocorticoid signalling by gene targeting. Endocr. Res. 1996, 22:641-652.
19. Bergmann A., Eulenberg C., Wellner M., Rolle S., Luft F., Kettritz R. Aldosterone abrogates nuclear factor kappaB-mediated tumor necrosis factor alpha production in human neutrophils via the mineralocorticoid receptor. Hypertension 2010, 55:370-379.
20. Biedasek K., Andres J., Mai K., Adams S., Spuler S., Fielitz J., Spranger J. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS ONE 2011, 6:e16674.
21. Binder H.J., White A., Whiting D., Hayslett J. Demonstration of specific high affinity receptors for aldosterone in cytosol of rat colon. Endocrinology 1986, 118:628-631.
22. Bostanjoglo M., Reeves W.B., Reilly R.F., Velazquez H., Robertson N., Litwack G., Morsing P., Dorup J., Bachmann S., Ellison D.H., Bostonjoglo M. 11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J. Am. Soc. Nephrol. 1998, 9:1347-1358.
23. Boylan M.T., Crockard A.D., McDonnell G.V., Armstrong M.A., Hawkins S.A. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone. J. Neurol. Sci. 1999, 167:79-89.
24. Brem A.S., Bina R.B., King T., Morris D.J. Bidirectional activity of 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle cells. Steroids 1995, 60:406-410.
25. Brem A.S., Bina R.B., King T.C., Morris D.J. Localization of 2 11beta-OH steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension 1998, 31:459-462.
26. Brereton P.S., van Driel R.R., Suhaimi F., Koyama K., Dilley R., Krozowski Z. Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat. Endocrinology 2001, 142:1644-1651.
27. Brown J.W., Fishman L.M., Carballeira A. Studies of the neuronal transdifferentiation process in cultured human pheochromocytoma cells: effects of steroids with differing functional groups on catecholamine content and cell morphology. Steroids 1998, 63:587-594.
28. Brown N.J. Aldosterone and vascular inflammation. Hypertension 2008, 51:161-167.
29. Bujalska I.J., Hewitt K.N., Hauton D., Lavery G.G., Tomlinson J.W., Walker E.A., Stewart P.M. Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue. Endocrinology 2008, 149:2584-2591.
30. Bunda S., Wang Y., Mitts T.F., Liu P., Arab S., Arabkhari M., Hinek A. Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 2009, 284:16633-16647.
31. Burniston J.G., Saini A., Tan L.B., Goldspink D.F. Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J. Mol. Cell. Cardiol. 2005, 39:395-399.
32. Buttgereit F., Zhou H., Kalak R., Gaber T., Spies C.M., Huscher D., Straub R.H., Modzelewski J., Dunstan C.R., Seibel M.J. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo. Arthritis Rheum. 2009, 60:1998-2007.
33. Caprio M., Newfell B.G., la Sala A., Baur W., Fabbri A., Rosano G., Mendelsohn M.E., Jaffe I.Z. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ. Res. 2008, 102:1359-1367.
34. Caprio M., Antelmi A., Chetrite G., Muscat A., Mammi C., Marzolla V., Fabbri A., Zennaro M.C., Feve B. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology 2011, 152:113-125.
35. Carter R.N., Paterson J.M., Tworowska U., Stenvers D.J., Mullins J.J., Seckl J.R., Holmes M.C. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent. J. Neuroendocrinol. 2009, 21:879-887.
36. Christ M., Douwes K., Eisen C., Bechtner G., Theisen K., Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 1995, 25:117-123.
37. Christ M., Zange J., Janson C.P., Muller K., Kuklinski P., Schmidt B.M., Tillmann H.C., Gerzer R., Wehling M. Hypoxia modulates rapid effects of aldosterone on oxidative metabolism in human calf muscle. J. Endocrinol. Invest. 2001, 24:587-597.
38. Christy C., Hadoke P.W., Paterson J.M., Mullins J.J., Seckl J.R., Walker B.R. 11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids. Hypertension 2003, 42:580-587.
39. Cintra A., Zoli M., Rosen L., Agnati L.F., Okret S., Wikstrom A.C., Gustaffsson J.A., Fuxe K. Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience 1994, 62:843-897.
40. Cole T.J. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 1995, 136:4693-4696.
41. Condon J., Gosden C., Gardener D., Nickson P., Hewison M., Howie A.J., Stewart P.M. Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J. Clin. Endocrinol. Metab. 1998, 83:4490-4497.
42. Connell J.M., Davies E. The new biology of aldosterone. J. Endocrinol. 2005, 186:1-20.
43. Cooper M.S., Bujalska I., Rabbitt E., Walker E.A., Bland R., Sheppard M.C., Hewison M., Stewart P.M. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J. Bone Miner. Res. 2001, 16:1037-1044.
44. Coulter C.L., Smith R.E., Stowasser M., Sasano H., Krozowski Z.S., Gordon R.D. Expression of 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma. Mol. Cell. Endocrinol. 1999, 154:71-77.
45. De Kloet E.R., Reul J.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987, 12:83-105.
46. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
47. De Kloet E.R., Van Acker S.A., Sibug R.M., Oitzl M.S., Meijer O.C., Rahmouni K., de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int. 2000, 57:1329-1336.
48. De Sousa Peixoto R.A., Turban S., Battle J.H., Chapman K.E., Seckl J.R., Morton N.M. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo. Endocrinology 2008, 149:1861-1868.
49. Dempster D.W., Moonga B.S., Stein L.S., Horbert W.R., Antakly T. Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J. Endocrinol. 1997, 154:397-406.
50. Dumas T.C., Gillette T., Ferguson D., Hamilton K., Sapolsky R.M. Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticity. J. Neurosci. 2010, 30:1712-1720.
51. Edwards C.R., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 2:986-989.
52. Egido J. Vasoactive hormones and renal sclerosis. Kidney Int. 1996, 49:578-597.
53. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Heintze U., Janke J., Luft F.C., Sharma A.M. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes. Res. 2004, 12:9-17.
54. Escher G., Galli I., Vishwanath B.S., Frey B.M., Frey F.J. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. J. Exp. Med. 1997, 186:189-198.
55. Farman N., Bonvalet J.P. Aldosterone binding in isolated tubules. III. Autoradiography along the rat nephron. Am. J. Physiol. 1983, 245:F606-F614.
56. Farman N., Bonvalet J.P. Aldosterone binding in isolated tubules. IV. Autoradiography along the nephron of the spontaneously hypertensive rat. Am. J. Physiol. 1985, 249:F99-F106.
57. Farman N., Oblin M.E., Lombes M., Delahaye F., Westphal H.M., Bonvalet J.P., Gasc J.M. Immunolocalization of gluco- and mineralocorticoid receptors in rabbit kidney. Am. J. Physiol. 1991, 260:C226-C233.
58. Fraccarollo D., Galuppo P., Schraut S., Kneitz S., van Rooijen N., Ertl G., Bauersachs J. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 2008, 51:905-914.
59. Fukushima K., Sasano H., Nagura H., Sasaki I., Matsuno S., Krozowski Z.S. Immunohistochemical localization of mineralocorticoid receptor in human gut. Tohoku J. Exp. Med. 1991, 165:155-163.
60. Funder J., Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 1996, 137:5264-5268.
61. Funder J.W., Feldman D., Edelman I.S. Specific aldosterone binding in rat kidney and parotid. J. Steroid Biochem. 1972, 3:209-218.
62. Funder J.W., Feldman D., Edelman I.S. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 1973, 92:994-1004.
63. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
64. Funder J.W., Pearce P.T., Smith R., Campbell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 1989, 125:2224-2226.
65. Gaillard D., Wabitsch M., Pipy B., Negrel R. Control of terminal differentiation of adipose precursor cells by glucocorticoids. J. Lipid Res. 1991, 32:569-579.
66. Gathercole L.L., Stewart P.M. Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. J. Steroid Biochem. Mol. Biol. 2010, 122:21-27.
67. Geerling J.C., Loewy A.D. Aldosterone-sensitive neurons in the nucleus of the solitary tract: efferent projections. J. Comp. Neurol. 2006, 497:223-250.
68. Geerling J.C., Loewy A.D. Aldosterone in the brain. Am. J. Physiol. 2009, 297:F559-F576.
69. Gomez-Sanchez C.E., de Rodriguez A.F., Romero D.G., Estess J., Warden M.P., Gomez-Sanchez M.T., Gomez-Sanchez E.P. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 2006, 147:1343-1348.
70. Gomez-Sanchez E.P. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 1986, 118:819-823.
71. Gomez-Sanchez E.P., Fort C.M., Gomez-Sanchez C.E. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am. J. Physiol. 1990, 258:E482-E484.
72. Gomez-Sanchez E.P., Venkataraman M.T., Thwaites D., Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 1990, 258:E649-E653.
73. Gomez-Sanchez E.P., Romero D.G., de Rodriguez A.F., Warden M.P., Krozowski Z., Gomez-Sanchez C.E. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology 2008, 149:525-533.
74. Gong R., Latif S., Morris D.J., Brem A.S. Co-localization of glucocorticoid metabolizing and prostaglandin synthesizing enzymes in rat kidney and liver. Life Sci. 2008, 83:725-731.
75. Gottfried-Blackmore A., Sierra A., McEwen B.S., Ge R., Bulloch K. Microglia express functional 11 beta-hydroxysteroid dehydrogenase type 1. Glia 2010, 58:1257-1266.
76. Greene E.L., Kren S., Hostetter T.H. Role of aldosterone in the remnant kidney model in the rat. J. Clin. Invest. 1996, 98:1063-1068.
77. Guo C., Ricchiuti V., Lian B.Q., Yao T.M., Coutinho P., Romero J.R., Li J., Williams G.H., Adler G.K. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008, 117:2253-2261.
78. Hadoke P.W., Christy C., Kotelevtsev Y.V., Williams B.C., Kenyon C.J., Seckl J.R., Mullins J.J., Walker B.R. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation 2001, 104:2832-2837.
79. Hannan, T.J., Mysorekar, I.U., Hung, C.S., Isaacson-Schmid, M.L., Hultgren, S.J., 2010. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6, pii. e1001042.
80. Harizi H., Mormede P., Corcuff J.B. Inter-strain differences in glucocorticoid and mineralocorticoid effects on macrophage and lymphocyte functions in mice. J. Neuroimmunol. 2008, 204:38-42.
81. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., Holmes M.C. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinology 2001, 142:114-120.
82. Haseroth K., Gerdes D., Berger S., Feuring M., Gunther A., Herbst C., Christ M., Wehling M. Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem. Biophys. Res. Commun. 1999, 266:257-261.
83. Herrada A.A., Contreras F.J., Marini N.P., Amador C.A., Gonzalez P.A., Cortes C.M., Riedel C.A., Carvajal C.A., Figueroa F., Michea L.F., Fardella C.E., Kalergis A.M. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J. Immunol. 2010, 184:191-202.
84. Hirasawa G., Sasano H., Takahashi K., Fukushima K., Suzuki T., Hiwatashi N., Toyota T., Krozowski Z.S., Nagura H. Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J. Clin. Endocrinol. Metab. 1997, 82:3859-3863.
85. Hirasawa G., Sasano H., Suzuki T., Takeyama J., Muramatu Y., Fukushima K., Hiwatashi N., Toyota T., Nagura H., Krozowski Z.S. 11Beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in human fetal development. J. Clin. Endocrinol. Metab. 1999, 84:1453-1458.
86. Hirata A., Maeda N., Hiuge A., Hibuse T., Fujita K., Okada T., Kihara S., Funahashi T., Shimomura I. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc. Res. 2009, 84:164-172.
87. Hodel A. Effects of glucocorticoids on adrenal chromaffin cells. J. Neuroendocrinol. 2001, 13:216-220.
88. Hofbauer L.C., Gori F., Riggs B.L., Lacey D.L., Dunstan C.R., Spelsberg T.C., Khosla S. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 1999, 140:4382-4389.
89. Holmes M.C., Carter R.N., Noble J., Chitnis S., Dutia A., Paterson J.M., Mullins J.J., Seckl J.R., Yau J.L. 11beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments. J. Neurosci. 2010, 30:6916-6920.
90. Hoppmann J., Perwitz N., Meier B., Fasshauer M., Hadaschik D., Lehnert H., Klein J. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J. Endocrinol. 2010, 204:153-164.
91. Hu G., Oboukhova E.A., Kumar S., Sturek M., Obukhov A.G. Canonical transient receptor potential channels expression is elevated in a porcine model of metabolic syndrome. Mol. Endocrinol. 2009, 23:689-699.
92. Hu X., Funder J.W. The evolution of mineralocorticoid receptors. Mol. Endocrinol. 2006, 20:1471-1478.
93. Huang S., Zhang A., Ding G., Chen R. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am. J. Physiol. 2009, 296:F1323-F1333.
94. Hubert C., Gasc J.M., Berger S., Schutz G., Corvol P. Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice. Mol. Endocrinol. 1999, 13:297-306.
95. Jaffe I.Z., Mendelsohn M.E. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ. Res. 2005, 96:643-650.
96. Jaffe I.Z., Tintut Y., Newfell B.G., Demer L.L., Mendelsohn M.E. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscl. Throm. Vas. 2007, 27:799-805.
97. Jang C., Obeyesekere V.R., Dilley R.J., Krozowski Z., Inder W.J., Alford F.P. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 2007, 92:3314-3320.
98. Jia D., O'Brien C.A., Stewart S.A., Manolagas S.C., Weinstein R.S. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 2006, 147:5592-5599.
99. Joels M., de Kloet E.R. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro. Proc. Natl Acad. Sci. USA 1990, 87:4495-4498.
100. Joyce D.A., Steer J.H., Abraham L.J. Glucocorticoid modulation of human monocyte/macrophage function: control of TNF-alpha secretion. Inflamm. Res. 1997, 46:447-451.
101. Kassahn K.S., Ragan M.A., Funder J.W. Mineralocorticoid receptors: evolutionary and pathophysiological considerations. Endocrinology 2011, 152:1883-1890.
102. Kato K., Sasano H., Ohara S., Sekine H., Mochizuki S., Mune T., Yasuda K., Nagura H., Shimosegawa T., Toyota T., Krozowski Z. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa. J. Clin. Endocrinol. Metab. 1999, 84:2568-2573.
103. Kayes-Wandover K.M., White P.C. Steroidogenic enzyme gene expression in the human heart. J. Clin. Endocrinol. Metab. 2000, 85:2519-2525.
104. Kenouch S., Lombes M., Delahaye F., Eugene E., Bonvalet J.P., Farman N. Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 1994, 79:1334-1341.
105. Kiefer R., Kreutzberg G.W. Effects of dexamethasone on microglial activation in vivo: selective downregulation of major histocompatibility complex class II expression in regenerating facial nucleus. J. Neuroimmunol. 1991, 34:99-108.
106. Klusonova P., Rehakova L., Borchert G., Vagnerova K., Neckar J., Ergang P., Miksik I., Kolar F., Pacha J. Chronic intermittent hypoxia induces 11beta-hydroxysteroid dehydrogenase in rat heart. Endocrinology 2009, 150:4270-4277.
107. Krozowski Z.S., Funder J.W. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl Acad. Sci. USA 1983, 80:6056-6060.
108. Kuster G.M., Kotlyar E., Rude M.K., Siwik D.A., Liao R., Colucci W.S., Sam F. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 2005, 111:420-427.
109. Lai L., Chen J., Hao C.M., Lin S., Gu Y. Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochem. Biophys. Res. Commun. 2006, 348:70-75.
110. Lastra-Lastra G., Sowers J.R., Restrepo-Erazo K., Manrique-Acevedo C., Lastra-Gonzalez G. Role of aldosterone and angiotensin II in insulin resistance. an update. Clin. Endocrinol. (Oxf.) 2009, 71:1-6.
111. Lastra G., Whaley-Connell A., Manrique C., Habibi J., Gutweiler A.A., Appesh L., Hayden M.R., Wei Y., Ferrario C., Sowers J.R. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E110-E116.
112. Lastra G., Dhuper S., Johnson M.S., Sowers J.R. Salt, aldosterone, and insulin resistance. impact on the cardiovascular system. Nat. Rev. Nephrol. 2010, 7:577-584.
113. Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J., Shackleton C.H., Parker K.L., White P.C., Stewart P.M. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J. Biol. Chem. 2006, 281:6546-6551.
114. Lavery G.G., Hauton D., Hewitt K.N., Brice S.M., Sherlock M., Walker E.A., Stewart P.M. Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 2007, 148:6100-6106.
115. Lavery G.G., Walker E.A., Turan N., Rogoff D., Ryder J.W., Shelton J.M., Richardson J.A., Falciani F., White P.C., Stewart P.M., Parker K.L., McMillan D.R. Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J. Biol. Chem. 2008, 283:8453-8461.
116. Le Menuet D., Munier M., Meduri G., Viengchareun S., Lombes M. Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency. Cardiovasc. Res. 2010, 87:467-475.
117. Lee M.J., Fried S.K., Mundt S.S., Wang Y., Sullivan S., Stefanni A., Daugherty B.L., Hermanowski-Vosatka A. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 2008, 16:1178-1185.
118. Lee S.H., Yoo T.H., Nam B.Y., Kim D.K., Li J.J., Jung D.S., Kwak S.J., Ryu D.R., Han S.H., Lee J.E., Moon S.J., Han D.S., Kang S.W. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions. Am. J. Physiol. 2009, 297:F1381-F1390.
119. Lightman S.L., Wiles C.C., Atkinson H.C., Henley D.E., Russell G.M., Leendertz J.A., McKenna M.A., Spiga F., Wood S.A., Conway-Campbell B.L. The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 2008, 583:255-262.
120. Lim H.Y., Muller N., Herold M.J., van den Brandt J., Reichardt H.M. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 2007, 122:47-53.
121. Liu G., Miyata K., Hitomi H., Yao L., Sun G.P., Suzaki Y., Hosomi N., Kiyomoto H., Nakano D., Tamaki T., Yoshizumi M., Nishiyama A. Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation. J. Hypertens. 2010, 28:536-542.
122. Liu W., Wang J., Sauter N.K., Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc. Natl Acad. Sci. USA 1995, 92:12480-12484.
123. Lombes M., Farman N., Oblin M.E., Baulieu E.E., Bonvalet J.P., Erlanger B.F., Gasc J.M. Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone. Proc. Natl Acad. Sci. USA 1990, 87:1086-1088.
124. Lombes M., Oblin M.E., Gasc J.M., Baulieu E.E., Farman N., Bonvalet J.P. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ. Res. 1992, 71:503-510.
125. Lombes M., Alfaidy N., Eugene E., Lessana A., Farman N., Bonvalet J.P. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 1995, 92:175-182.
126. Lopez-Andres N., Inigo C., Gallego I., Diez J., Fortuno M.A. Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes. Endocrinology 2008, 149:4970-4978.
127. Losel R.M., Wehling M. Classic versus non-classic receptors for nongenomic mineralocorticoid responses: emerging evidence. Front. Neuroendocrinol. 2008, 29:258-267.
128. Lother A., Berger S., Gilsbach R., Rosner S., Ecke A., Barreto F., Bauersachs J., Schutz G., Hein L. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function. Hypertension 2011, 57:746-754.
129. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1998, 1:69-73.
130. Makrygiannakis D., af Klint E., Catrina S.B., Botusan I.R., Klareskog E., Klareskog L., Ulfgren A.K., Catrina A.I. Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. Arthritis Rheum. 2006, 54:1463-1472.
131. Mathew J.T., Patni H., Chaudhary A.N., Liang W., Gupta A., Chander P.N., Ding G., Singhal P.C. Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. Am. J. Physiol. 2008, 295:F73-F81.
132. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220:911-912.
133. McEwen B.S., De Kloet E.R., Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 1986, 66:1121-1188.
134. Mihailidou A.S., Mardini M., Funder J.W. Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology 2004, 145:773-780.
135. Milford D.V., Shackleton C.H., Stewart P.M. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin. Endocrinol. (Oxf) 1995, 43:241-246.
136. Miller A.H., Spencer R.L., Hassett J., Kim C., Rhee R., Ciurea D., Dhabhar F., McEwen B., Stein M. Effects of selective type I and II adrenal steroid agonists on immune cell distribution. Endocrinology 1994, 135:1934-1944.
137. Mitts T.F., Bunda S., Wang Y., Hinek A. Aldosterone and mineralocorticoid receptor antagonists modulate elastin and collagen deposition in human skin. J. Invest. Dermatol. 2010, 130:2396-2406.
138. Miyata K., Rahman M., Shokoji T., Nagai Y., Zhang G.X., Sun G.P., Kimura S., Yukimura T., Kiyomoto H., Kohno M., Abe Y., Nishiyama A. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol. 2005, 16:2906-2912.
139. Montano Loza A.J., Czaja A.J. Current therapy for autoimmune hepatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007, 4:202-214.
140. Moore X.L., Hoong I., Cole T.J. Expression of the 11beta-hydroxysteroid dehydrogenase 2 gene in the mouse. Kidney Int. 2000, 57:1307-1312.
141. Morgan S.A., Sherlock M., Gathercole L.L., Lavery G.G., Lenaghan C., Bujalska I.J., Laber D., Yu A., Convey G., Mayers R., Hegyi K., Sethi J.K., Stewart P.M., Smith D.M., Tomlinson J.W. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Diabetes 2009, 58:2506-2515.
142. Morimoto M., Morita N., Ozawa H., Yokoyama K., Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 1996, 26:235-269.
143. Napolitano A., Voice M.W., Edwards C.R., Seckl J.R., Chapman K.E. 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J. Steroid Biochem. Mol. Biol. 1998, 64:251-260.
144. Naray-Fejes-Toth A., Fejes-Toth G. Subcellular localization of the type 2 11beta-hydroxysteroid dehydrogenase. A green fluorescent protein study. J. Biol. Chem. 1996, 271:15436-15442.
145. Naray-Fejes-Toth A., Fejes-Toth G. Extranuclear localization of endogenous 11beta-hydroxysteroid dehydrogenase-2 in aldosterone target cells. Endocrinology 1998, 139:2955-2959.
146. Naray-Fejes-Toth A., Fejes-Toth G. Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells. Am. J. Physiol. 2007, 292:F486-F494.
147. Nichols N.R., Agolley D., Zieba M., Bye N. Glucocorticoid regulation of glial responses during hippocampal neurodegeneration and regeneration. Brain Res. Mol. Brain Res. 2005, 48:287-301.
148. Nishikawa T., Suematsu S., Saito J., Soyama A., Ito H., Kino T., Chrousos G. Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J. Steroid Biochem. Mol. Biol. 2005, 96:309-316.
149. Nishiyama A., Yao L., Nagai Y., Miyata K., Yoshizumi M., Kagami S., Kondo S., Kiyomoto H., Shokoji T., Kimura S., Kohno M., Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004, 43:841-848.
150. Nishiyama A., Yao L., Fan Y., Kyaw M., Kataoka N., Hashimoto K., Nagai Y., Nakamura E., Yoshizumi M., Shokoji T., Kimura S., Kiyomoto H., Tsujioka K., Kohno M., Tamaki T., Kajiya F., Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 2005, 45:710-716.
151. Nishiyama A., Kobori H., Konishi Y., Morikawa T., Maeda I., Okumura M., Kishida M., Hamada M., Nagai Y., Nakagawa T., Ohashi N., Nakano D., Hitomi H., Imanishi M. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J. Pharmacol. Exp. Ther. 2010, 332:1072-1080.
152. Odermatt A., Arnold P., Stauffer A., Frey B.M., Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J. Biol. Chem. 1999, 274:28762-28770.
153. Odermatt A., Arnold P., Frey F.J. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J. Biol. Chem. 2001, 276:28484-28492.
154. Ouvrard-Pascaud A., Sainte-Marie Y., Benitah J.P., Perrier R., Soukaseum C., Cat A.N., Royer A., Le Quang K., Charpentier F., Demolombe S., Mechta-Grigoriou F., Beggah A.T., Maison-Blanche P., Oblin M.E., Delcayre C., Fishman G.I., Farman N., Escoubet B., Jaisser F. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 2005, 111:3025-3033.
155. Park Y.S., Ha Choi Y., Park C.H., Kim K.T. Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells. Endocrinology 2008, 149:4921-4927.
156. Pelletier G., Luu-The V., Li S., Bujold G., Labrie F. Localization and glucocorticoid regulation of 11beta-hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain. Neuroscience 2007, 145:110-115.
157. Penfornis P., Viengchareun S., Le Menuet D., Cluzeaud F., Zennaro M.C., Lombes M. The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E386-E394.
158. Perez P., Page A., Bravo A., Del Rio M., Gimenez-Conti I., Budunova I., Slaga T.J., Jorcano J.L. Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor. FASEB J. 2001, 15:2030-2032.
159. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N. Engl. J. Med. 1999, 341:709-717.
160. Pitt B., Reichek N., Willenbrock R., Zannad F., Phillips R.A., Roniker B., Kleiman J., Krause S., Burns D., Williams G.H. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 2003, 108:1831-1838.
161. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 2003, 348:1309-1321.
162. Porter G.A., Bogoroch R., Edelman I.S. On the Mechanism of Action of Aldosterone on Sodium Transport: the Role of Rna Synthesis. Proc. Natl. Acad. Sci. USA 1964, 52:1326-1333.
163. Qin W., Rudolph A.E., Bond B.R., Rocha R., Blomme E.A., Goellner J.J., Funder J.W., McMahon E.G. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ. Res. 2003, 93:69-76.
164. Rafestin-Oblin M.E., Lombes M., Michiel J.B., Michaud A., Claire M. Mineralocorticoid receptors in the epithelial cells of human colon and ileum. J Steroid Biochem 1984, 20:311-315.
165. Rajan V., Edwards C.R., Seckl J.R. 11 beta-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J. Neurosci. 1996, 16:65-70.
166. Reini S.A., Wood C.E., Jensen E., Keller-Wood M. Increased maternal cortisol in late-gestation ewes decreases fetal cardiac expression of 11beta-HSD2 mRNA and the ratio of AT1 to AT2 receptor mRNA. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R1708-R1716.
167. Rickard A.J., Morgan J., Tesch G., Funder J.W., Fuller P.J., Young M.J. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009, 54:537-543.
168. Robert V., Van Thiem N., Cheav S.L., Mouas C., Swynghedauw B., Delcayre C. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994, 24:30-36.
169. Robertson N.M., Schulman G., Karnik S., Alnemri E., Litwack G. Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy. Mol. Endocrinol. 1993, 7:1226-1239.
170. Robson A.C., Leckie C.M., Seckl J.R., Holmes M.C. 11 Beta-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res. Mol. Brain Res. 1998, 61:1-10.
171. Rocha R., Stier C.T., Kifor I., Ochoa-Maya M.R., Rennke H.G., Williams G.H., Adler G.K. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000, 141:3871-3878.
172. Rocha R., Martin-Berger C.L., Yang P., Scherrer R., Delyani J., McMahon E. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 2002, 143:4828-4836.
173. Rocha R., Rudolph A.E., Frierdich G.E., Nachowiak D.A., Kekec B.K., Blomme E.A., McMahon E.G., Delyani J.A. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1802-H1810.
174. Rogoff D., Ryder J.W., Black K., Yan Z., Burgess S.C., McMillan D.R., White P.C. Abnormalities of glucose homeostasis and the hypothalamic-pituitary-adrenal axis in mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 2007, 148:5072-5080.
175. Roland B.L., Krozowski Z.S., Funder J.W. Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol. Cell. Endocrinol. 1995, 111:R1-R7.
176. Rossier M.F., Python M., Maturana A.D. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes. Endocrinology 2010, 151:2777-2787.
177. Rundle S.E., Funder J.W., Lakshmi V., Monder C. The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies. Endocrinology 1989, 125:1700-1704.
178. Sainte Marie Y., Toulon A., Paus R., Maubec E., Cherfa A., Grossin M., Descamps V., Clemessy M., Gasc J.M., Peuchmaur M., Glick A., Farman N., Jaisser F. Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am. J. Pathol. 2007, 171:846-860.
179. Sarabdjitsingh R.A., Isenia S., Polman A., Mijalkovic J., Lachize S., Datson N., de Kloet E.R., Meijer O.C. Disrupted corticosterone pulsatile patterns attenuate responsiveness to glucocorticoid signaling in rat brain. Endocrinology 2010, 151:1177-1186.
180. Sato A., Hayashi K., Naruse M., Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003, 41:64-68.
181. Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 2002, 96:23-43.
182. Schulman G., Miller-Diener A., Litwack G., Bastl C.P. Characterization of the rat colonic aldosterone receptor and its activation process. J. Biol. Chem. 1986, 261:12102-12108.
183. Semjonous N.M., Sherlock M., Jeyasuria P., Parker K.L., Walker E.A., Stewart P.M., Lavery G.G. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 2011, 152:93-102.
184. Senesi S., Marcolongo P., Manini I., Fulceri R., Sorrentino V., Csala M., Banhegyi G., Benedetti A. Constant expression of hexose-6-phosphate dehydrogenase during differentiation of human adipose-derived mesenchymal stem cells. J. Mol. Endocrinol. 2008, 41:125-133.
185. Sheppard K., Funder J.W. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies. Am. J. Physiol. 1987, 252:E224-E229.
186. Shimojo M., Whorwood C.B., Stewart P.M. 11 beta-Hydroxysteroid dehydrogenase in the rat adrenal. J. Mol. Endocrinol. 1996, 17:121-130.
187. Sinclair A.J., Onyimba C.U., Khosla P., Vijapurapu N., Tomlinson J.W., Burdon M.A., Stewart P.M., Murray P.I., Walker E.A., Rauz S. Corticosteroids, 11beta-hydroxysteroid dehydrogenase isozymes and the rabbit choroid plexus. J. Neuroendocrinol. 2007, 19:614-620.
188. Slominski A., Gomez-Sanchez C.E., Foecking M.F., Wortsman J. Active steroidogenesis in the normal rat skin. Biochim. Biophys. Acta 2000, 1474:1-4.
189. Smith R.E., Maguire J.A., Stein-Oakley A.N., Sasano H., Takahashi K., Fukushima K., Krozowski Z.S. Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues. J. Clin. Endocrinol. Metab. 1996, 81:3244-3248.
190. Sooy K., Webster S.P., Noble J., Binnie M., Walker B.R., Seckl J.R., Yau J.L. Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice. J. Neurosci. 2010, 30:13867-13872.
191. Staab C.A., Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J. Steroid Biochem. Mol. Biol. 2010, 119:56-72.
192. Takeda Y. Pathophysiological roles of vascular 11beta-hydroxysteroid dehydrogenase and aldosterone. J. Steroid Biochem. Mol. Biol. 2003, 85:443-447.
193. Tanahashi K., Hori S.H. Immunohistochemical localization of hexose 6-phosphate dehydrogenase in various organs of the rat. J. Histochem. Cytochem. 1980, 28:1175-1182.
194. Tanaka J., Fujita H., Matsuda S., Toku K., Sakanaka M., Maeda N. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia 1997, 20:23-37.
195. Terada Y., Kobayashi T., Kuwana H., Tanaka H., Inoshita S., Kuwahara M., Sasaki S. Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A. J. Am. Soc. Nephrol. 2005, 16:2296-2305.
196. Thieringer R., Le Grand C.B., Carbin L., Cai T.Q., Wong B., Wright S.D., Hermanowski-Vosatka A. 11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J. Immunol. 2001, 167:30-35.
197. Tiganescu A., Walker E.A., Hardy R.S., Mayes A.E., Stewart P.M. Localization, age- and site-dependent expression, and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in skin. J. Invest. Dermatol. 2011, 131:30-36.
198. Tischner D., Reichardt H.M. Glucocorticoids in the control of neuroinflammation. Mol. Cell. Endocrinol. 2007, 275:62-70.
199. Trapp T., Rupprecht R., Castren M., Reul J.M., Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 1994, 13:1457-1462.
200. Tsugita M., Iwasaki Y., Nishiyama M., Taguchi T., Shinahara M., Taniguchi Y., Kambayashi M., Terada Y., Hashimoto K. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells. Life Sci. 2008, 83:426-432.
201. Turchin A., Guo C.Z., Adler G.K., Ricchiuti V., Kohane I.S., Williams G.H. Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology 2006, 147:3183-3189.
202. Uhrenholt T.R., Schjerning J., Hansen P.B., Norregaard R., Jensen B.L., Sorensen G.L., Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ. Res. 2003, 93:1258-1266.
203. Urbach V., Van Kerkhove E., Maguire D., Harvey B.J. Rapid activation of KATP channels by aldosterone in principal cells of frog skin. J. Physiol. 1996, 491(Pt 1):111-120.
204. Usher M.G., Duan S.Z., Ivaschenko C.Y., Frieler R.A., Berger S., Schutz G., Lumeng C.N., Mortensen R.M. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. Clin. Invest. 2010, 120:3350-3364.
205. van Steensel B., van Binnendijk E.P., Hornsby C.D., van der Voort H.T., Krozowski Z.S., de Kloet E.R., van Driel R. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J. Cell Sci. 1996, 109(Pt 4):787-792.
206. Virdis A., Neves M.F., Amiri F., Viel E., Touyz R.M., Schiffrin E.L. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002, 40:504-510.
207. Walker B.R., Yau J.L., Brett L.P., Seckl J.R., Monder C., Williams B.C., Edwards C.R. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 1991, 129:3305-3312.
208. Wehling M., Kasmayr J., Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway?. Am. J. Physiol. 1991, 260:E719-E726.
209. Wehling M., Neylon C.B., Fullerton M., Bobik A., Funder J.W. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ. Res. 1995, 76:973-979.
210. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 1998, 102:274-282.
211. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
212. Whorwood C.B., Donovan S.J., Flanagan D., Phillips D.I., Byrne C.D. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 2002, 51:1066-1075.
213. Wiegers G.J., Reul J.M., Holsboer F., de Kloet E.R. Enhancement of rat splenic lymphocyte mitogenesis after short term preexposure to corticosteroids in vitro. Endocrinology 1994, 135:2351-2357.
214. Wilson P., Morgan J., Funder J.W., Fuller P.J., Young M.J. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart. Clin. Sci. (Lond) 2009, 116:731-739.
215. Yao W., Cheng Z., Busse C., Pham A., Nakamura M.C., Lane N.E. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 2008, 58:1674-1686.
216. Yau J.L., Noble J., Kenyon C.J., Hibberd C., Kotelevtsev Y., Mullins J.J., Seckl J.R. Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. USA 2001, 98:4716-4721.
217. Yau J.L., Noble J., Hibberd C., Rowe W.B., Meaney M.J., Morris R.G., Seckl J.R. Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J. Neurosci. 2002, 22:1436-1442.
218. Yau J.L., Noble J., Seckl J.R. 11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control. J. Neurosci. 2011, 31:4188-4193.
219. Yoshida M., Ma J., Tomita T., Morikawa N., Tanaka N., Masamura K., Kawai Y., Miyamori I. Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure. Congest Heart Fail 2005, 11:12-16.
220. Young M., Fullerton M., Dilley R., Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 1994, 93:2578-2583.
221. Young M., Head G., Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 1995, 269:E657-E662.
222. Zbankova S., Bryndova J., Leden P., Kment M., Svec A., Pacha J. 11beta-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis. J. Gastroen. Hepatol. 2007, 22:1019-1023.
223. Zennaro M.C., Farman N., Bonvalet J.P., Lombes M. Tissue-specific expression of alpha and beta messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. J. Clin. Endocrinol. Metab. 1997, 82:1345-1352.
224. Zhang M., Chen J., Lai L., You L., Lin S., Hao C., Gu Y. Aldosterone promotes fibronectin synthesis in rat mesangial cells via ERK1/2-stimulated Na-H+ exchanger isoform 1. Am. J. Nephrol. 2010, 31:75-82.